BioSymetrics
Phenomics-driven AI company translating disease biology into precision medicine discoveries.
Check the tech stack behind biosymetrics.com. Find a founder email at biosymetrics.com.
About
BioSymetrics is a phenomics-driven company that leverages AI and in vivo validation to translate complex human disease biology into discoveries. Their platform connects disease phenotype and genotype data, using machine learning predictions to identify higher-confidence targets and precision medicines. Teams look it up for Biotech, HealthTech, Drug Discovery.
Frequently asked
What does BioSymetrics do?
BioSymetrics is a Biotech company that offers Platform. Teams look it up for HealthTech, Drug Discovery, Genomics. It is based in Boston, United States and was founded in 2017. Public records show about 14 people and $7M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has BioSymetrics raised?
BioSymetrics has raised a total of $7M in funding. The most recent round on record is Seed.
Where is BioSymetrics headquartered?
BioSymetrics is headquartered in Boston, United States.
When was BioSymetrics founded?
BioSymetrics was founded in 2017.
What industry does BioSymetrics operate in?
BioSymetrics operates in Biotech, HealthTech, Drug Discovery, Genomics, AI-Driven Drug Discovery.
How many employees does BioSymetrics have?
BioSymetrics has approximately 14 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.